263 related articles for article (PubMed ID: 20689132)
41. Diagnostic markers for early detection of ovarian cancer.
Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
[TBL] [Abstract][Full Text] [Related]
42. Biomarkers for lung cancer: clinical uses.
Greenberg AK; Lee MS
Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
[TBL] [Abstract][Full Text] [Related]
43. Challenges for biomarkers in cancer detection.
Wagner PD; Verma M; Srivastava S
Ann N Y Acad Sci; 2004 Jun; 1022():9-16. PubMed ID: 15251933
[TBL] [Abstract][Full Text] [Related]
44. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
[TBL] [Abstract][Full Text] [Related]
45. Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer.
Mirandola L; J Cannon M; Cobos E; Bernardini G; Jenkins MR; Kast WM; Chiriva-Internati M
Int Rev Immunol; 2011; 30(2-3):127-37. PubMed ID: 21557639
[TBL] [Abstract][Full Text] [Related]
46. Clinical proteomics and biomarker discovery.
Johann DJ; McGuigan MD; Patel AR; Tomov S; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA
Ann N Y Acad Sci; 2004 Jun; 1022():295-305. PubMed ID: 15251975
[TBL] [Abstract][Full Text] [Related]
47. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
48. The ovarian cancer-derived secretory/releasing proteome: A repertoire of tumor markers.
Zhang Y; Xu B; Liu Y; Yao H; Lu N; Li B; Gao J; Guo S; Han N; Qi J; Zhang K; Cheng S; Wang H; Zhang X; Xiao T; Wu L; Gao Y
Proteomics; 2012 Jun; 12(11):1883-91. PubMed ID: 22623176
[TBL] [Abstract][Full Text] [Related]
49. Screening and detection of ovarian cancer.
Breedlove G; Busenhart C
J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
[TBL] [Abstract][Full Text] [Related]
50. [New advances in screening and treatment of ovarian cancer].
Morice P; Pautier P; Bidart JM
Bull Cancer; 2003 Jan; 90(1):53-60. PubMed ID: 12609805
[TBL] [Abstract][Full Text] [Related]
51. [Innovations in biomarker development: a pathway towards individualized cancer therapy?].
Dumitru CA; Hoffmann TK; Lehnerdt G; Zeidler R; Lang S; Brandau S
Laryngorhinootologie; 2011 Mar; 90(3):168-77. PubMed ID: 21380962
[TBL] [Abstract][Full Text] [Related]
52. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
53. Ovarian cancer biomarkers for molecular biosensors and translational medicine.
Suh KS; Park SW; Castro A; Patel H; Blake P; Liang M; Goy A
Expert Rev Mol Diagn; 2010 Nov; 10(8):1069-83. PubMed ID: 21080822
[TBL] [Abstract][Full Text] [Related]
54. Advances in tumor markers of ovarian cancer for early diagnosis.
Dong X; Men X; Zhang W; Lei P
Indian J Cancer; 2014 Mar; 51 Suppl 3():e72-6. PubMed ID: 25818738
[TBL] [Abstract][Full Text] [Related]
55. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Nossov V; Amneus M; Su F; Lang J; Janco JM; Reddy ST; Farias-Eisner R
Am J Obstet Gynecol; 2008 Sep; 199(3):215-23. PubMed ID: 18468571
[TBL] [Abstract][Full Text] [Related]
56. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers.
Slupsky CM; Steed H; Wells TH; Dabbs K; Schepansky A; Capstick V; Faught W; Sawyer MB
Clin Cancer Res; 2010 Dec; 16(23):5835-41. PubMed ID: 20956617
[TBL] [Abstract][Full Text] [Related]
57. Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays.
Ramirez AB; Lampe PD
Cancer Biomark; 2010-2011; 8(4-5):293-307. PubMed ID: 22045360
[TBL] [Abstract][Full Text] [Related]
58. Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers.
Hariprasad G; Hariprasad R; Kumar L; Srinivasan A; Kola S; Kaushik A
Biomarkers; 2013 Sep; 18(6):532-41. PubMed ID: 23902290
[TBL] [Abstract][Full Text] [Related]
59. [Proteomics and biomarkers for detection of ovarian cancer].
Kacerovský M; Tambor V; Lenco J; Tosner J
Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
[TBL] [Abstract][Full Text] [Related]
60. Biomarkers for early detection of ovarian cancer.
Nguyen L; Cardenas-Goicoechea SJ; Gordon P; Curtin C; Momeni M; Chuang L; Fishman D
Womens Health (Lond); 2013 Mar; 9(2):171-85; quiz 186-7. PubMed ID: 23477323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]